Abstract:Background and Purpose-Understanding the factors that contribute to early readmission after discharge following stroke is limited. We aimed to describe the factors associated with 28-day readmission after hospitalization for stroke. Methods-Factors associated with readmission were classified from the medical record standardized audits of 50 to 100 consecutively admitted patients with stroke from 35 Australian hospitals during multiple time periods (2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(20… Show more
“…Several studies have been undertaken to examine the frequency of readmissions within 30 days of discharge after stroke [13,27]. Evidence from these studies show that the frequency of hospital readmissions may vary from 6.5% to 24.3% [27]. The readmission rate in our study was comparable to what has been reported using Medicare data (12-14%) or single center studies (10%) [11].…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625supporting
confidence: 78%
“…The second important finding from our study is that the frequency of all-cause readmission in this study was 8.5% at 30 days and 18.5% at 90 days after discharge. Several studies have been undertaken to examine the frequency of readmissions within 30 days of discharge after stroke [13,27]. Evidence from these studies show that the frequency of hospital readmissions may vary from 6.5% to 24.3% [27].…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625mentioning
confidence: 99%
“…Patients with strokes, who are readmitted within 30 days, are at a higher risk of mortality in the long term and incur greater healthcare costs [10,28]. The potential factors that may be associated with being readmitted after an initial hospitalization for stroke can be grouped into 5 broad categories: patient characteristics, social circumstances, health system, clinical care, and health outcome [27]. In this study, prior hospitalization was significantly associated with all-cause readmission at 30 days (p= 0.034).…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625mentioning
Purpose: In stroke patients, a group at high risk for readmission, there is limited information on medication persistence and its impact on readmission. Utilizing data from a quality improvement program for post-acute processes of care, we investigated the relationship between secondary prevention medication persistence and risk for 90-day readmission in acute stroke patients.
Methods:Patients were eligible for the study if they were age 18 years or older and hospitalized with a primary diagnosis of acute ischemic or hemorrhagic stroke, or transient ischemic attack (TIA). A total of 142 patients who had been enrolled in the Transition Coaching for Stroke (TRACS) program were included in the analysis.
Results:The mean age was 63.6 ± 13.13 years and 52.8% were women. History of a prior stroke was significantly associated with medication non-persistence (p=0.013, odds ratio [OR], 4.85; 95% confidence interval [CI] 1.39-16.96). History of a prior stroke was also significantly associated with readmission for recurrent stroke or TIA within 30 days of discharge (p= 0.029, OR 7.00; 95% CI 1. 22-40.23). Logistic regression modeling with stroke/TIA readmission at 90 days showed that only prior stroke was significant (p= 0.012, OR 5.54; 95% CI 1.45-21.10). A trend toward lower medication persistence was observed in patients readmitted with a stroke/TIA within 90 days (60.0% vs. 81.8%, p=0.095).
Conclusions:In patients discharged with stroke, history of a prior stroke was significantly associated with stroke/TIA readmission at 30 and 90 days after discharge. Poor secondary prevention medication persistence may be a potential risk factor for stroke/TIA readmission. Quality improvement programs focused on improving medication persistence may be essential, especially in patients with a history of recurrent strokes.
“…Several studies have been undertaken to examine the frequency of readmissions within 30 days of discharge after stroke [13,27]. Evidence from these studies show that the frequency of hospital readmissions may vary from 6.5% to 24.3% [27]. The readmission rate in our study was comparable to what has been reported using Medicare data (12-14%) or single center studies (10%) [11].…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625supporting
confidence: 78%
“…The second important finding from our study is that the frequency of all-cause readmission in this study was 8.5% at 30 days and 18.5% at 90 days after discharge. Several studies have been undertaken to examine the frequency of readmissions within 30 days of discharge after stroke [13,27]. Evidence from these studies show that the frequency of hospital readmissions may vary from 6.5% to 24.3% [27].…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625mentioning
confidence: 99%
“…Patients with strokes, who are readmitted within 30 days, are at a higher risk of mortality in the long term and incur greater healthcare costs [10,28]. The potential factors that may be associated with being readmitted after an initial hospitalization for stroke can be grouped into 5 broad categories: patient characteristics, social circumstances, health system, clinical care, and health outcome [27]. In this study, prior hospitalization was significantly associated with all-cause readmission at 30 days (p= 0.034).…”
Section: Journal Of Neurology and Neuroscience Issn 2171-6625mentioning
Purpose: In stroke patients, a group at high risk for readmission, there is limited information on medication persistence and its impact on readmission. Utilizing data from a quality improvement program for post-acute processes of care, we investigated the relationship between secondary prevention medication persistence and risk for 90-day readmission in acute stroke patients.
Methods:Patients were eligible for the study if they were age 18 years or older and hospitalized with a primary diagnosis of acute ischemic or hemorrhagic stroke, or transient ischemic attack (TIA). A total of 142 patients who had been enrolled in the Transition Coaching for Stroke (TRACS) program were included in the analysis.
Results:The mean age was 63.6 ± 13.13 years and 52.8% were women. History of a prior stroke was significantly associated with medication non-persistence (p=0.013, odds ratio [OR], 4.85; 95% confidence interval [CI] 1.39-16.96). History of a prior stroke was also significantly associated with readmission for recurrent stroke or TIA within 30 days of discharge (p= 0.029, OR 7.00; 95% CI 1. 22-40.23). Logistic regression modeling with stroke/TIA readmission at 90 days showed that only prior stroke was significant (p= 0.012, OR 5.54; 95% CI 1.45-21.10). A trend toward lower medication persistence was observed in patients readmitted with a stroke/TIA within 90 days (60.0% vs. 81.8%, p=0.095).
Conclusions:In patients discharged with stroke, history of a prior stroke was significantly associated with stroke/TIA readmission at 30 and 90 days after discharge. Poor secondary prevention medication persistence may be a potential risk factor for stroke/TIA readmission. Quality improvement programs focused on improving medication persistence may be essential, especially in patients with a history of recurrent strokes.
“…6,9 Furthermore, the few hospital-based studies have used different methodologies and have included only limited data on disease severity, hospital course, and outcomes. [10][11][12][13] A recent review of hospital standards for quality reporting of readmissions after stroke concluded that future work should focus on identifying risk factors at the patient level that are not typically or reliably included in administrative data sets. 14 Although identification of predictors for stroke readmission is important, many previously identified factors including age and initial stroke severity are nonmodifiable and thus provide limited opportunity for targeted interventions.…”
“…Past research on the association between smoking status and readmission rates has produced equivocal results. [26][27][28][29][30][31][32][33][34] Many studies have examined commonly collected demographic variables. It has been reported that increasing age could potentially serve as a predictor of all-cause hospital readmissions, especially in patients over the age of 65.…”
Objective: Hospital readmissions are significant and potentially preventable sources of healthcare cost in the United States. The Affordable Care Act (ACA) establishes the Hospital Readmissions Reduction Program (HRRP) in an attempt to reduce readmissions by penalizing institutions whose 30-day readmission rates are above the national average. The current study examines demographic and clinical variables associated with early hospital readmission in a low socioeconomic status, underserved population. Methods: A secondary data analysis was conducted of 2,536 patients from the acute primary care facilities who were hospitalized. Age, sex, race, ethnicity, smoking status, systolic blood pressure, diastolic blood pressure, body temperature, pulse rate, and days to follow up visit were analyzed in a sample of 2,536 hospitalized patients at or below 200% of federal poverty guidelines in Central Texas to determine association with risk of 0-30-(30), 31-60-(60) and 61-90-(90) day all-cause readmission. Results: Multinomial statistical analysis found pulse rate was associated with 30-, 60-, and 90-day readmission as compared to a control group. Days to follow-up were associated with decreased risk of readmission in all groups, and passive smoking status was associated with decreased risk of 90-day readmission as compared to a control group. Conclusions: Results offer healthcare providers with tools for potentially identifying patients at elevated risk for readmission in a disadvantaged population and suggest further investigation of other clinical and laboratory variables as predictors of readmission risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.